M&A

Undone: Aurobindo Pharma's Rs.420-Cr deal with Cronus cancelled

BSE Announcement  

Aurobindo Pharma's INR 420 crore deal to acquire 51% stake in fellow Hyderabad-based Cronus Pharma Specialities has been cancelled.

Want to receive such news items in your inbox? Click Here to sign up for a trial.

2021 © TSJ Media Pvt Ltd. All rights reserved.